Salvage Re-Irradiation for Recurrent Head and Neck Cancer

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

Nancy Lee, Ping Xia, Jeanne M. Quivey et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 991 citations

Medicine, Oncology, Radiation Oncology +11

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 753 citations

Medicine, Oncology, Pharmacotherapy +13

Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group

Michael K. Gibson, Yi Li, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2005 · 494 citations

Medicine, Oncology, Pharmacology +14

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

Bruce Brockstein, Daniel J. Haraf, Alfred Rademaker et al. · Annals of Oncology · 2004 · 374 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

R. de Crevoisier, Jean Bourhis, C. Domenge et al. · Journal of Clinical Oncology · 1998 · 315 citations

Medicine, Oncology, Radiation Oncology +9